Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Avicenna.AI, a French artificial intelligence (AI) startup co-founded by a radiologist, has received U.S. Food and Drug Administration (FDA) clearance for two new offerings designed to automatically identify cardiovascular findings in CT scans, CINA-iPE and CINA-ASPECTS.

Radiology AI company gains FDA clearance for new CT offerings focused on PE, stroke

The newly approved AI models are designed to improve the detection of pulmonary embolisms and strokes in patients who undergo CT scans.

Virtual reality (VR) can help cardiologists plan for transcatheter aortic valve replacement (TAVR) procedures and predict the presence and severity of post-TAVR paravalvular leak (PVL), according to new research published in the Journal of Invasive Cardiology.[1]

VR before TAVR predicts paravalvular leak in high-risk patients

Performing virtual reality simulations before TAVR may help cardiologists anticipate when PVL could be an issue in patients with severe BAV AS.

artificial intelligence robot evaluates healthcare data

New AI model predicts cancer risk based on breast asymmetry

The program is a simplified modification of the popular Mirai deep-learning algorithm, developed by researchers at MIT to predict future cancer.

Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster takes key step toward FDA approval for Varipulse PFA system

The company already received CE mark approval for its new PFA offering and hopes it will soon be approved for sale in the United States.

healthcare value value-based care money dollar

Novo Nordisk to acquire biotech company working on new heart failure drug for $1.1B

Cardior Pharmaceuticals in Germany has been developing a new compound it says can “halt and partially reverse cellular pathology” in heart failure patients. 

The most popular selfie spot at ACC 2023. At one point the first day of the conference, there were about 1,0000 attendees waiting in a line about two football fields long to get a photo in front of the logo. A testament to the first post-COVID pandemic ACC and large numbers of returning clinicians to the in person event. ACC.23 had more attendees and vendor booths than in 0re-pandemic 2019. #ACC23 #ACC

ACC.24 to make the business side of cardiology a priority

While the American College of Cardiology's annual meeting has historically had a more clinical focus, presentations at this year's conference in Atlanta will spend much more time looking at the business side of things. 

Medicare money payment

Medicare will now cover weight loss drug semaglutide if taken for heart benefits

The news represents a meaningful policy shift for CMS. In the past, Medicare prescription drug plans have not covered medications designed to help patients lose weight.

Going green in the cath lab makes economic sense

New research explored the potential savings of turning off angiography systems at night and on weekends.

Displaying 1201 - 1208 of 6427
Design by Adaptive Theme